Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:NTGNYSEARCA:SDYCNSX:VP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNTGTortoise Midstream Energy Fund$53.36$54.39$38.71▼$59.45N/AN/A13,035 shs24,436 shsSDYSPDR S&P Dividend ETF$131.58+0.5%$132.06$119.83▼$144.45$19.45B0.8259,792 shs196,716 shsVPVodis Pharmaceuticals$0.00$0.16▼$0.62N/AN/A1,714 shs51,582 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNTGTortoise Midstream Energy Fund0.00%0.00%0.00%0.00%+37.56%SDYSPDR S&P Dividend ETF-0.49%-0.06%+4.00%-2.46%+1.33%VPVodis Pharmaceuticals0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNTGTortoise Midstream Energy FundN/AN/AN/AN/AN/AN/AN/AN/ASDYSPDR S&P Dividend ETFN/AN/AN/AN/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNTGTortoise Midstream Energy Fund 0.00N/AN/AN/ASDYSPDR S&P Dividend ETF 2.46Hold$131.58N/AVPVodis Pharmaceuticals 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNTGTortoise Midstream Energy Fund$75.79MN/AN/AN/AN/AN/ASDYSPDR S&P Dividend ETFN/AN/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNTGTortoise Midstream Energy FundN/A-$0.03N/A∞N/AN/AN/AN/AN/ASDYSPDR S&P Dividend ETFN/AN/A20.17∞N/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNTGTortoise Midstream Energy Fund$3.165.92%N/AN/A N/ASDYSPDR S&P Dividend ETF$4.283.25%N/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNTGTortoise Midstream Energy FundN/ASDYSPDR S&P Dividend ETFN/AVPVodis PharmaceuticalsN/AInsider OwnershipCompanyInsider OwnershipNTGTortoise Midstream Energy FundN/ASDYSPDR S&P Dividend ETFN/AVPVodis PharmaceuticalsN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNTGTortoise Midstream Energy FundN/AN/AN/ANot OptionableSDYSPDR S&P Dividend ETFN/A147.85 millionN/ANot OptionableVPVodis PharmaceuticalsN/AN/AN/ANot OptionableSDY, NTG, VP, and ASY HeadlinesRecent News About These CompaniesVP debate 'spin room' scene: Talking points and unscripted momentsOctober 22, 2024 | usatoday.comPharma execs donated more to Democrats in campaign’s final stretchOctober 21, 2024 | statnews.comVitalPath hires Nicole Ramus as global sales VPOctober 18, 2024 | medicaldesignandoutsourcing.comVice President Harris in ‘Excellent Health,’ Medical Report StatesOctober 14, 2024 | msn.comVance Confident, Walz Uneven in VP Debate Heavy on PolicyOctober 2, 2024 | wsj.comRead the full VP debate transcript from the Walz-Vance showdownOctober 2, 2024 | cbsnews.comAs Investigations Swirl, Another Adams Official ResignsSeptember 24, 2024 | nytimes.comTHE CONTRERAS REPORT: Governor Newsom, veto Big Pharma’s grab for more profitsSeptember 24, 2024 | ivpressonline.comTris Pharma Promotes Naidu to Chief Commercial OfficerSeptember 21, 2024 | njbmagazine.comNo one used to care about the vice presidency. Here's how (and why) that's changed.September 15, 2024 | pbs.orgTonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial OperationsSeptember 10, 2024 | markets.businessinsider.comKalVista Pharma Appoints Brian Piekos As New CFOSeptember 10, 2024 | markets.businessinsider.comFor pharma, Trump versus Harris is a showdown between two industry foesAugust 27, 2024 | politifact.comAvive names Katerina Miras as VP of marketingAugust 21, 2024 | massdevice.comThis Bipartisan Bill Would Upend America's Pharmaceutical IndustryAugust 20, 2024 | forbes.comHow they are reporting it: Kamala Harris' VP pick, Tim WalzAugust 9, 2024 | reuters.comKamala Harris campaign expected to announce VP running mate Tuesday morningAugust 7, 2024 | cbsnews.comVP Pick Walz’s Healthcare Policies Align With Harris’s RecordAugust 7, 2024 | forbes.comWhere VP picks stand on pharmaceutical costsAugust 6, 2024 | beckershospitalreview.comWhere Harris' VP Options Stand on HealthcareAugust 2, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSDY, NTG, VP, and ASY Company DescriptionsTortoise Midstream Energy Fund NYSE:NTGTortoise MLP Fund, Inc. is a close ended equity mutual fund launched and managed by Tortoise Capital Advisors L.L.C. It invests in public equity markets. The fund primarily invests in equity securities of MLPs and their affiliates, with an emphasis on natural gas infrastructure Master Limited Partnerships. It employs a fundamental analysis with a bottom up stock picking approach with focus on factors like quantitative, qualitative, and relative value factors to create its portfolio. Tortoise MLP Fund, Inc. was formed on July 27, 2010 is domiciled in United States.SPDR S&P Dividend ETF NYSEARCA:SDY$131.58 +0.67 (+0.51%) Closing price 04:10 PM EasternExtended Trading$131.33 -0.25 (-0.19%) As of 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The SPDR S&P Dividend ETF seeks to closely match the returns and characteristics of the S&P High Yield Dividend Aristocrats Index (the Index). The Index is designed to measure the performance of the 60 highest dividend yielding S&P Composite 1500 Index constituents that have followed a managed-dividends policy of consistently increasing dividends every year for at least 25 consecutive years. The Fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds (including money market funds advised by the Adviser). SSgA Funds Management, Inc. is the investment adviser to the Fund.Vodis Pharmaceuticals CNSX:VPVodis Pharmaceuticals Inc. operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Disney Stock Jumps on Earnings—Is the Magic Sustainable? AMD Relieves Market Despite Ongoing Share Price Outlook Caution Gold’s Record Run in 2025: Here Are 3 Ways to Ride the Surge What the New Quarter Says About Super Micro Computer's Future Archer Stock Eyes Q1 Earnings After UAE Updates Ford Motor Stock Rises After Earnings, But Momentum May Not Last Broadcom Stock Gets a Lift on Hyperscaler Earnings & CapEx Boost Lemonade Delivers Sweet Results, Price Reversal to Accelerate Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
